{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:35:32Z","timestamp":1771475732842,"version":"3.50.1"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ZIA BC 011657"],"award-info":[{"award-number":["ZIA BC 011657"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Multimodality therapy including surgical resection is the current paradigm in treating malignant pleural mesothelioma (MPM), a thoracic surface cancer without cure. The main limitation of all surgical approaches is the lack of long-term durability because macroscopic complete resection (R1 resection) commonly predisposes to locoregional relapse. Over the years, there have been many studies that describe various intrapleural strategies that aim to extend the effect of surgical resection. The majority of these approaches are intraoperative adjuvants. Broadly, there are three therapeutic classes that employ diverse agents. The most common, widely used group of adjuvants are comprised of direct therapeutics such as intracavitary chemotherapy (\u00b1 hyperthermia). By comparison, the least commonly employed intrathoracic adjuvant is the class comprised of drug-device combinations like photodynamic therapy (PDT). But the most rapidly evolving (new) class with much potential for improved efficacy are therapeutics delivered by specialized drug vehicles such as a fibrin gel containing cisplatin. This review provides an updated perspective on pleural-directed adjuncts in the management of MPM as well as highlighting the most promising near-term technology breakthroughs.<\/jats:p>","DOI":"10.3389\/fonc.2022.886430","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T05:22:32Z","timestamp":1651468952000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Current State of Pleural-Directed Adjuncts Against Malignant Pleural Mesothelioma"],"prefix":"10.3389","volume":"12","author":[{"given":"Agnes Y.","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthik","family":"Pittala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuong D.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"B1","unstructured":"Malignant Pleural Mesothelioma2022"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.08.001","article-title":"Surgery in Malignant Pleural Mesothelioma","volume":"13","author":"Bueno","year":"2018","journal-title":"J Thorac Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2013.11.026","article-title":"A Systematic Review and Meta-Analysis of Surgical Treatments for Malignant Pleural Mesothelioma","volume":"83","author":"Cao","year":"2014","journal-title":"Lung Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2014.10.128","article-title":"Updated Patterns of Failure After Multimodality Therapy for Malignant Pleural Mesothelioma","volume":"149","author":"Baldini","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0090-8258(85)90118-0","article-title":"Clinical Pharmacology of Intraperitoneal Cisplatin","volume":"20","author":"Lopez","year":"1985","journal-title":"Gynecol Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.6.1001","article-title":"Intrapleural Cisplatin and Mitomycin for Malignant Mesothelioma Following Pleurectomy: Pharmacokinetic Studies","volume":"10","author":"Rusch","year":"1992","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.6.1156","article-title":"A Phase II Trial of Pleurectomy\/Decortication Followed by Intrapleural and Systemic Chemotherapy for Malignant Pleural Mesothelioma","volume":"12","author":"Rusch","year":"1994","journal-title":"J Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(99)70297-7","article-title":"Pleural Space Perfusion With Cisplatin in the Multimodality Treatment of Malignant Mesothelioma: A Feasibility and Pharmacokinetic Study","volume":"117","author":"Ratto","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"955","DOI":"10.21037\/atm-20-5444","article-title":"Hyperthermic Intrathoracic Chemotherapy (Hithoc): Narrative Review of the Current Literature, Recommendations and Future Studies","volume":"9","author":"Markowiak","year":"2021","journal-title":"Ann Transl Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.04.032","article-title":"A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma","volume":"13","author":"Burt","year":"2018","journal-title":"J Thorac Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.04.93","article-title":"Pleurectomy\/Decortication and Hyperthermic Intrathoracic Chemoperfusion Using Cisplatin and Doxorubicin for Malignant Pleural Mesothelioma","volume":"11","author":"Klotz","year":"2019","journal-title":"J Thorac Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"960","DOI":"10.21037\/atm-20-7247","article-title":"Hyperthermic Intrathoracic Chemotherapy (Hithoc) Should Be Included in the Guidelines for Malignant Pleural Mesothelioma","volume":"9","author":"Migliore","year":"2021","journal-title":"Ann Transl Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s1055-3207(03)00029-2","article-title":"Rationale for Hyperthermia With Intraoperative Intraperitoneal Chemotherapy Agents","volume":"12","author":"Sticca","year":"2003","journal-title":"Surg Oncol Clin North Am"},{"key":"B14","article-title":"Effects of Hyperthermia on Blood Flow and Cis-Diamminedichloroplatinum(Ii) Pharmacokinetics in Murine Mammary Adenocarcinomas","volume":"52","author":"Ausmus","year":"1992","journal-title":"Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jtcvs.2012.10.042","article-title":"Intraoperative Hyperthermic Chemotherapy Perfusion for Malignant Pleural Mesothelioma: An In Vitro Evaluation","volume":"145","author":"Cameron","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2017.06.073","article-title":"Povidone Iodine in Wound Healing: A Review of Current Concepts and Practices","volume":"44","author":"Bigliardi","year":"2017","journal-title":"Int J Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/s0003-4975(01)03083-1","article-title":"Accelerated Treatment for Early and Late Postpneumonectomy Empyema","volume":"72","author":"Schneiter","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2014.10.041","article-title":"Pleurectomy\/Decortication, Hyperthermic Pleural Lavage With Povidone-Iodine, Prophylactic Radiotherapy, and Systemic Chemotherapy in Patients With Malignant Pleural Mesothelioma: A 10-Year Experience","volume":"149","author":"Lang-Lazdunski","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/ejcts\/ezt534","article-title":"Antineoplastic Activity of Povidone-Iodine on Different Mesothelioma Cell Lines: Results of in Vitro Study","volume":"45","author":"Fiorelli","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2007.01.024","article-title":"Taurolidine and Povidone-Iodine Induce Different Types of Cell Death in Malignant Pleural Mesothelioma","volume":"56","author":"Opitz","year":"2007","journal-title":"Lung Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(83)90155-1","article-title":"Regulation of the Cytoskeleton in Mesothelial Cells: Reversible Loss of Keratin and Increase in Vimentin During Rapid Growth in Culture","volume":"34","author":"Connell","year":"1983","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivy248","article-title":"Povidone-Iodine Results in Rapid Killing of Thymic Epithelial Tumour Cells Through Cellular Fixationdagger","volume":"28","author":"Lee","year":"2019","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2006.11.046","article-title":"A Phase Ii Study of Intrapleural Immuno-Chemotherapy, Pleurectomy\/Decortication, Radiotherapy, Systemic Chemotherapy and Long-Term Sub-Cutaneous Il-2 in Stage Ii-Iii Malignant Pleural Mesothelioma","volume":"31","author":"Lucchi","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-Line Nivolumab Plus Ipilimumab in Unresectable Malignant Pleural Mesothelioma (Checkmate 743): A Multicentre, Randomised, Open-Label, Phase 3 Trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/0305-7372(95)90004-7","article-title":"Potential for Cytokine Therapy of Malignant Mesothelioma","volume":"21","author":"Fitzpatrick","year":"1995","journal-title":"Cancer Treat Rev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/139.6.1369","article-title":"Lysis of Human Malignant Mesothelioma Cells by Natural Killer (Nk) and Lymphokine-Activated Killer (Lak) Cells","volume":"139","author":"Manning","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19981115)83:10<2099::aid-cncr8>3.0.co;2-3","article-title":"Intrapleural Administration of Interleukin-2 for the Treatment of Patients With Malignant Pleural Mesothelioma: A Phase II Study","volume":"83","author":"Astoul","year":"1998","journal-title":"Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940115)73:2<308::aid-cncr2820730213>3.0.co;2-4","article-title":"Pharmacokinetics of Intrapleural Recombinant Interleukin-2 in Immunotherapy for Malignant Pleural Effusion","volume":"73","author":"Astoul","year":"1994","journal-title":"Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jtcvs.2005.08.012","article-title":"Intrapleural Topical Application of Cisplatin With the Surgical Carrier Vivostat Increases the Local Drug Concentration in an Immune-Competent Rat Model With Malignant Pleuromesothelioma","volume":"131","author":"Lardinois","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jtcvs.2010.09.032","article-title":"Optimized Intrapleural Cisplatin Chemotherapy With a Fibrin Carrier After Extrapleural Pneumonectomy: A Preclinical Study","volume":"141","author":"Opitz","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2019.07.073","article-title":"Intracavitary Cisplatin-Fibrin Chemotherapy After Surgery for Malignant Pleural Mesothelioma: A Phase I Trial","volume":"159","author":"Opitz","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/s0003-4975(98)00470-6","article-title":"Vivostat System Autologous Fibrin Sealant: Preliminary Study in Elective Coronary Bypass Grafting","volume":"66","author":"Kjaergard","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"B33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/10611860802095494","article-title":"An Insight on Hyaluronic Acid in Drug Targeting and Drug Delivery","volume":"16","author":"Yadav","year":"2008","journal-title":"J Drug Target"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2009.08.012","article-title":"Intrapleural Polymeric Films Containing Cisplatin for Malignant Pleural Mesothelioma in a Rat Tumour Model: A Preliminary Study","volume":"37","author":"Ampollini","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.10.74","article-title":"Polymeric Films Loaded With Cisplatin for Malignant Pleural Mesothelioma: A Pharmacokinetic Study in an Ovine Model","volume":"10","author":"Ampollini","year":"2018","journal-title":"J Thorac Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22016","article-title":"Pharmacokinetics and Disposition of a Localized Lymphatic Polymeric Hyaluronan Conjugate of Cisplatin in Rodents","volume":"99","author":"Cai","year":"2010","journal-title":"J Pharm Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1021\/ja807416t","article-title":"Expansile Nanoparticles: Synthesis, Characterization, and in Vivo Efficacy of an Acid-Responsive Polymeric Drug Delivery System","volume":"131","author":"Griset","year":"2009","journal-title":"J Am Chem Soc"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2019.12.076","article-title":"Paclitaxel-Loaded Expansile Nanoparticles Improve Survival Following Cytoreductive Surgery in Pleural Mesothelioma Xenografts","volume":"160","author":"Chu","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.246","article-title":"Microrna Therapeutics: Towards a New Era for the Management of Cancer and Other Diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-021-00961-w","article-title":"Surface-Fill Hydrogel Attenuates the Oncogenic Signature of Complex Anatomical Surface Cancer in a Single Application","volume":"16","author":"Majumder","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.7150\/thno.16358","article-title":"Targeting Negative Surface Charges of Cancer Cells by Multifunctional Nanoprobes","volume":"6","author":"Chen","year":"2016","journal-title":"Theranostics"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.05.020","article-title":"Microrna-215-5p Treatment Suppresses Mesothelioma Progression Via the Mdm2-P53-Signaling Axis","volume":"27","author":"Singh","year":"2019","journal-title":"Mol Ther"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2021.04.001","article-title":"Microrna-206 Suppresses Mesothelioma Progression Via the Ras Signaling Axis","volume":"24","author":"Singh","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical Development and Potential of Photothermal and Photodynamic Therapies for Cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2012.02.009","article-title":"Radical Pleurectomy and Intraoperative Photodynamic Therapy for Malignant Pleural Mesothelioma","volume":"93","author":"Friedberg","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2014.09.017","article-title":"Photodynamic Therapy for Lung Cancer and Malignant Pleural Mesothelioma","volume":"41","author":"Simone","year":"2014","journal-title":"Semin Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2014.12.077","article-title":"Intrapleural Photodynamic Therapy for Mesothelioma: What Place and Which Future","volume":"99","author":"Munck","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/BF02303746","article-title":"Phase Iii Randomized Trial of Surgery With or Without Intraoperative Photodynamic Therapy and Postoperative Immunochemotherapy for Malignant Pleural Mesothelioma","volume":"4","author":"Pass","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1572-1000(04)00009-2","article-title":"Photodynamic Therapy Enhanced by Hyperbaric Oxygenation in Palliation of Malignant Pleural Mesothelioma: Clinical Experience","volume":"1","author":"Matzi","year":"2004","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1367","article-title":"Exploiting Tumour Hypoxia in Cancer Treatment","volume":"4","author":"Brown","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.11.015","article-title":"To Exploit the Tumor Microenvironment: Since the Epr Effect Fails in the Clinic, What Is the Future of Nanomedicine","volume":"244","author":"Danhier","year":"2016","journal-title":"J Control Release"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.886430\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T05:22:36Z","timestamp":1651468956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.886430\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":51,"alternative-id":["10.3389\/fonc.2022.886430"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.886430","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"article-number":"886430"}}